215 related articles for article (PubMed ID: 37319315)
1. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
3. Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.
Zhang S; Kuang G; Huang Y; Huang X; Wang W; Wang G
Hum Genomics; 2022 Apr; 16(1):14. PubMed ID: 35449086
[TBL] [Abstract][Full Text] [Related]
4. RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.
Song P; Zhou S; Qi X; Jiao Y; Gong Y; Zhao J; Yang H; Qian Z; Qian J; Tang L
J Bioinform Comput Biol; 2022 Apr; 20(2):2250004. PubMed ID: 35287562
[No Abstract] [Full Text] [Related]
5. A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.
Li X; Zhou Y; Jiang Q; Huang J; Liu Z; Li Y; Guo G
Funct Integr Genomics; 2023 May; 23(2):162. PubMed ID: 37188931
[TBL] [Abstract][Full Text] [Related]
6. Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer.
Gao W; Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Yu X
Front Immunol; 2022; 13():1031184. PubMed ID: 36601127
[TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
8. RNA m
Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
Front Immunol; 2022; 13():905057. PubMed ID: 36389669
[TBL] [Abstract][Full Text] [Related]
9. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
10. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
Front Immunol; 2022; 13():921223. PubMed ID: 35860263
[TBL] [Abstract][Full Text] [Related]
12. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
Front Genet; 2022; 13():761681. PubMed ID: 35154267
[No Abstract] [Full Text] [Related]
13. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Zhou B; Bie F; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Zhao J; Gao S
EBioMedicine; 2022 Oct; 84():104268. PubMed ID: 36116215
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.
Zhang S; Xiong Y; Zheng C; Long J; Zhou H; Zeng Z; Ouyang Y; Tang F
Front Cell Dev Biol; 2022; 10():821678. PubMed ID: 35155433
[TBL] [Abstract][Full Text] [Related]
15. Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.
Han X; Lu H; Tang X; Zhao Y; Liu H
Immun Inflamm Dis; 2022 Jan; 10(1):43-59. PubMed ID: 34582114
[TBL] [Abstract][Full Text] [Related]
16. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
[TBL] [Abstract][Full Text] [Related]
17. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer.
Wang C; Chen Y; Zhou R; Yang Y; Fang Y
Curr Med Chem; 2024; 31(17):2467-2482. PubMed ID: 37936456
[TBL] [Abstract][Full Text] [Related]
18. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
19. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
20. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]